2018 印度专家共识:淋巴瘤的管理

2018-07-30 国外血液科相关专家小组 Indian J Hematol Blood Transfus. 2018 Jul;34(3):39

淋巴瘤的临床进程主要取决于疾病的活跃度和侵袭性,淋巴瘤的最佳治疗需要基于正确的诊断以及分类。本文的主要目的是为临床医生针对年龄>18岁成人淋巴瘤患者的临床管理提供指导。主要内容涉及弥漫性大B细胞淋巴瘤,霍奇金淋巴瘤,滤泡性淋巴瘤,T细胞淋巴瘤,慢性淋巴细胞白血病/小淋巴细胞淋巴瘤,伯基特淋巴瘤和间变性大细胞淋巴瘤的详细治疗方案。

中文标题:

2018 印度专家共识:淋巴瘤的管理

英文标题:

Management of Lymphomas: Consensus Document 2018 by an Indian Expert Group.

发布日期:

2018-07-30

简要介绍:

淋巴瘤的临床进程主要取决于疾病的活跃度和侵袭性,淋巴瘤的最佳治疗需要基于正确的诊断以及分类。本文的主要目的是为临床医生针对年龄>18岁成人淋巴瘤患者的临床管理提供指导。主要内容涉及弥漫性大B细胞淋巴瘤,霍奇金淋巴瘤,滤泡性淋巴瘤,T细胞淋巴瘤,慢性淋巴细胞白血病/小淋巴细胞淋巴瘤,伯基特淋巴瘤和间变性大细胞淋巴瘤的详细治疗方案。 

拓展指南:淋巴瘤相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2018 印度专家共识:淋巴瘤的管理)] GetToolGuiderByIdResponse(projectId=1, id=e19b41c0016335f8, title=2018 印度专家共识:淋巴瘤的管理, enTitle=Management of Lymphomas: Consensus Document 2018 by an Indian Expert Group., guiderFrom=Indian J Hematol Blood Transfus. 2018 Jul;34(3):39, authorId=null, author=, summary=淋巴瘤的临床进程主要取决于疾病的活跃度和侵袭性,淋巴瘤的最佳治疗需要基于正确的诊断以及分类。本文的主要目的是为临床医生针对年龄>18岁成人淋巴瘤患者的临床管理提供指导。主要内容涉及弥漫性大B细胞淋巴瘤,霍奇金淋巴瘤,滤泡性淋巴瘤,T细胞淋巴瘤,慢性淋巴细胞白血病/小淋巴细胞淋巴瘤,伯基特淋巴瘤和间变性大细胞淋巴瘤的详细治疗方案。 , cover=, journalId=null, articlesId=null, associationId=971, associationName=国外血液科相关专家小组, associationIntro=null, copyright=0, guiderPublishedTime=Mon Jul 30 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>淋巴瘤的临床进程主要取决于疾病的活跃度和侵袭性,淋巴瘤的最佳治疗需要基于正确的诊断以及分类。本文的主要目的是为临床医生针对年龄>18岁成人淋巴瘤患者的临床管理提供指导。主要内容涉及弥漫性大B细胞淋巴瘤,霍奇金淋巴瘤,滤泡性淋巴瘤,T细胞淋巴瘤,慢性淋巴细胞白血病/小淋巴细胞淋巴瘤,伯基特淋巴瘤和间变性大细胞淋巴瘤的详细治疗方案。 </div> <div><br> </div>拓展指南:<strong>与<font color=red>淋巴瘤</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=2ffa51c00162911a" title="2018 ILROG指南:中枢神经系统淋巴瘤放射治疗" target=_blank>2018 ILROG指南:中枢神经系统淋巴瘤放射治疗</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=33dd01c0016288a6" title="NCCN临床实践指南:巨球蛋白血症/淋巴浆细胞性淋巴瘤(2019.V1)" target=_blank>NCCN临床实践指南:巨球蛋白血症/淋巴浆细胞性淋巴瘤(2019.V1)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=8501f1c00162e883" title="NCCN临床实践指南:T细胞淋巴瘤(2018.V5)" target=_blank>NCCN临床实践指南:T细胞淋巴瘤(2018.V5)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=6ca7b1c001626ec1" title="NCCN临床实践指南:慢性淋巴细胞白血病/小淋巴细胞淋巴瘤(2019.V1)" target=_blank>NCCN临床实践指南:慢性淋巴细胞白血病/小淋巴细胞淋巴瘤(2019.V1)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=d28911c001608ef9" title="《中国慢性淋巴细胞白血病/小淋巴细胞淋巴瘤的诊断与治疗指南(2018年版)》解读" target=_blank>《中国慢性淋巴细胞白血病/小淋巴细胞淋巴瘤的诊断与治疗指南(2018年版)》解读</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E6%B7%8B%E5%B7%B4%E7%98%A4" target=_blank>有关淋巴瘤更多指南</a></ul>, tagList=[TagDto(tagId=412, tagName=淋巴瘤)], categoryList=[CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3626, appHits=87, showAppHits=0, pcHits=2717, showPcHits=1215, likes=84, shares=5, comments=14, approvalStatus=1, publishedTime=Wed Aug 29 23:09:59 CST 2018, publishedTimeString=2018-07-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Wed Aug 29 23:09:59 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 13:09:17 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 印度专家共识:淋巴瘤的管理)])
2018 印度专家共识:淋巴瘤的管理
下载请点击:
评论区 (14)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=362736, encodeId=eb5e362e36c8, content=下载的存在哪里的?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38b92568268, createdName=12579d04m01暂无昵称, createdTime=Sat Mar 16 10:32:28 CST 2019, time=2019-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=344222, encodeId=e860344222bb, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Mon Sep 10 00:07:01 CST 2018, time=2018-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=344221, encodeId=74943442213e, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Mon Sep 10 00:06:58 CST 2018, time=2018-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=344220, encodeId=75e134422007, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Mon Sep 10 00:06:54 CST 2018, time=2018-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=344219, encodeId=2a5e34421982, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Mon Sep 10 00:06:51 CST 2018, time=2018-09-10, status=1, ipAttribution=)]
    2019-03-16 12579d04m01暂无昵称

    下载的存在哪里的?

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=362736, encodeId=eb5e362e36c8, content=下载的存在哪里的?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38b92568268, createdName=12579d04m01暂无昵称, createdTime=Sat Mar 16 10:32:28 CST 2019, time=2019-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=344222, encodeId=e860344222bb, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Mon Sep 10 00:07:01 CST 2018, time=2018-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=344221, encodeId=74943442213e, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Mon Sep 10 00:06:58 CST 2018, time=2018-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=344220, encodeId=75e134422007, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Mon Sep 10 00:06:54 CST 2018, time=2018-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=344219, encodeId=2a5e34421982, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Mon Sep 10 00:06:51 CST 2018, time=2018-09-10, status=1, ipAttribution=)]
    2018-09-10 xiaotao112411

    学习学习学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=362736, encodeId=eb5e362e36c8, content=下载的存在哪里的?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38b92568268, createdName=12579d04m01暂无昵称, createdTime=Sat Mar 16 10:32:28 CST 2019, time=2019-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=344222, encodeId=e860344222bb, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Mon Sep 10 00:07:01 CST 2018, time=2018-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=344221, encodeId=74943442213e, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Mon Sep 10 00:06:58 CST 2018, time=2018-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=344220, encodeId=75e134422007, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Mon Sep 10 00:06:54 CST 2018, time=2018-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=344219, encodeId=2a5e34421982, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Mon Sep 10 00:06:51 CST 2018, time=2018-09-10, status=1, ipAttribution=)]
    2018-09-10 xiaotao112411

    学习学习学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=362736, encodeId=eb5e362e36c8, content=下载的存在哪里的?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38b92568268, createdName=12579d04m01暂无昵称, createdTime=Sat Mar 16 10:32:28 CST 2019, time=2019-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=344222, encodeId=e860344222bb, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Mon Sep 10 00:07:01 CST 2018, time=2018-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=344221, encodeId=74943442213e, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Mon Sep 10 00:06:58 CST 2018, time=2018-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=344220, encodeId=75e134422007, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Mon Sep 10 00:06:54 CST 2018, time=2018-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=344219, encodeId=2a5e34421982, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Mon Sep 10 00:06:51 CST 2018, time=2018-09-10, status=1, ipAttribution=)]
    2018-09-10 xiaotao112411

    学习学习学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=362736, encodeId=eb5e362e36c8, content=下载的存在哪里的?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38b92568268, createdName=12579d04m01暂无昵称, createdTime=Sat Mar 16 10:32:28 CST 2019, time=2019-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=344222, encodeId=e860344222bb, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Mon Sep 10 00:07:01 CST 2018, time=2018-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=344221, encodeId=74943442213e, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Mon Sep 10 00:06:58 CST 2018, time=2018-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=344220, encodeId=75e134422007, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Mon Sep 10 00:06:54 CST 2018, time=2018-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=344219, encodeId=2a5e34421982, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Mon Sep 10 00:06:51 CST 2018, time=2018-09-10, status=1, ipAttribution=)]
    2018-09-10 xiaotao112411

    学习学习学习

    0